The breast cancer susceptibility protein, BRCA2, is essential for recombinational DNA repair. BRCA2 delivers RAD51 to double-stranded DNA (dsDNA) breaks through interaction with eight conserved, $35 amino acid motifs, the BRC repeats. Here we show that the solitary BRC4 promotes assembly of RAD51 onto single-stranded DNA (ssDNA), but not dsDNA, to stimulate DNA strand exchange. BRC4 acts by blocking ATP hydrolysis and thereby maintaining the active ATP-bound form of the RAD51-ssDNA filament. Single-molecule visualization shows that BRC4 does not disassemble RAD51-dsDNA filaments but rather blocks nucleation of RAD51 onto dsDNA. Furthermore, this behavior is manifested by a domain of BRCA2 comprising all eight BRC repeats. These results establish that the BRC repeats modulate RAD51-DNA interaction in two opposing but functionally reinforcing ways: targeting active RAD51 to ssDNA and prohibiting RAD51 nucleation onto dsDNA. Thus, BRCA2 recruits RAD51 to DNA breaks and, we propose, the BRC repeats regulate DNA-binding selectivity.
INTRODUCTION
The breast cancer susceptibility gene, BRCA2, encodes a protein of 3418 amino acids (Wooster et al., 1995) . BRCA2 is needed for DNA repair by homologous recombination (Moynahan et al., 2001; Tutt et al., 2001) , the predominant mechanism employed by cells to accurately repair double-strand breaks (DBSs). The inability to purify full-length BRCA2 protein has hampered analysis of its role in this essential biological process. However, crystallographic studies revealed that BRCA2 possesses both a DNA-binding domain (DBD), with unique structural features for binding ssDNA and dsDNA (Yang et al., 2002) , and BRC repeats, which bind to the core of RAD51 by mimicking the structure of an adjacent RAD51 monomer (Pellegrini et al., 2002) . Electron microscopy uncovered two different loci for binding to RAD51, the N-terminal domain and the nucleotide-binding core (Galkin et al., 2005) . In addition, another RAD51-binding site was mapped to the C terminus of BRCA2 (Esashi et al., 2007) . Together, these results suggest that the intact BRCA2 protein might bind both DNA and RAD51 and deliver RAD51 to the sites of DNA breaks (Kowalczykowski, 2005; Pellegrini et al., 2002; Shin et al., 2003; Yang et al., 2002) .
The importance of the BRC motifs to BRCA2 function in the maintenance of genome integrity is supported by observations showing that point mutations within BRC that compromise interactions with RAD51 are found in individuals predisposed to breast cancer (Breast Cancer Information Core, http:// research.nhgri.nih.gov/bic/). At least one BRC repeat, in concert with the DBD of BRCA2, is required for targeting RAD51 to ssDNA (San Filippo et al., 2006) . Moreover, a fusion of a BRC repeat with the large subunit of the human ssDNAbinding protein, Replication protein-A (RPA), is sufficient to suppress cellular defects found in brca2 mutant mammalian cells (Saeki et al., 2006) . In fact, exogenous expression of mutants deleted for the BRC repeats or with missense mutations that give rise to familial cancers eliminates the ability of BRCA2 to restore resistance to methyl methanesulphonate (MMS) (Chen et al., 1998) . However, apparently contradictory effects reported for the BRC repeats on RAD51 behavior have confounded molecular understanding of their function. For instance, BRC repeats are reported to both block assembly of the RAD51 nucleoprotein filament on dsDNA and paradoxically stabilize the same nucleoprotein filament (Chen et al., 1999; Davies et al., 2001; Galkin et al., 2005; Shivji et al., 2006) . These seemingly disparate observations may simply reflect experimental differences among the various studies, or instead they may suggest an unappreciated complexity in the mechanism by which the BRC repeats regulate RAD51 function. Here we use ensemble-and single-molecule methods to examine the effects of the BRC4 repeat on RAD51 nucleoprotein filament assembly on both ssDNA and dsDNA. We uncover a dichotomy with regard to the effect of BRC4 and a BRCA2 domain including the eight repeats, BRCA2 , on these two types of DNA: BRC4 and BRCA2 BRC1-8 stabilize filament formation on ssDNA but prevent filament formation on dsDNA. The consequence of this control over DNA selection results in an enhancement of the DNA strand exchange activity of RAD51 protein by the BRC repeats that we propose is a function within the intact BRCA2 protein. Stimulate the Formation of RAD51 Nucleoprotein Filaments on ssDNA Because prior studies had not specifically focused on the role of BRC repeats in RAD51 nucleoprotein filament on ssDNA, we decided to first examine the effect of the well-characterized BRC4 repeat (Pellegrini et al., 2002) on the assembly of RAD51 onto ssDNA. BRC4 was purified as a fusion with glutathione-S-transferase (GST); as controls, a GST-fused repeat with a deletion, D1524-30, and a GST-fused repeat with a point mutation, T1526A ( Figure S1 available online), each of which fails to bind RAD51 (Chen et al., 1999; Davies et al., 2001 ) (confirmed using a GST pull-down assays; data not shown), were also purified. For the ssDNA, to avoid the ambiguity introduced by dsDNA that results from secondary structure forming within native ssDNA, the homopolymer, dT 40 , was initially used. BRC4 was incubated with RAD51, ssDNA added, and then the complexes were analyzed using electrophoretic mobility shift assays (EMSA). As expected, BRC4 alone does not bind the ssDNA ( Figure 1A , lane 1). In the presence of ATP, the RAD51 nucleoprotein filaments are partially stable and only $30% of the DNA is shifted ( Figure 1A , lane 2). The addition of BRC4 unexpectedly produced a BRC4 concentration-dependent increase in RAD51-ssDNA complexes from 30% to almost 100% (lanes 3-8), whereas the control peptides, D1524-30 (lanes 9 and 10 and Figure 1B ) or T1526A ( Figure 1B) , had no effect. Maximum stimulation occurred at about 12 mM of peptide and then declined at higher concentrations of BRC4 ( Figures 1A-1C) . (D) BRC4 increases the stability of RAD51-ssDNA complexes to increasing salt concentrations; complexes were formed with RAD51 (0.9 mM) alone (upper panel) or RAD51 (0.9 mM) and GST-BRC4 (3.6 mM) (lower panel), in the presence of ADP and Mg The EMSA in Figure 1A was obtained using a mixture of Ca 2+ and Mg 2+ , which resulted in better defined RAD51-ssDNA complexes due to their greater kinetic stability imparted by the Ca 2+ (Bugreev and Mazin, 2004) . However, even when Ca 2+ was omitted, BRC4 stabilized the RAD51 nucleoprotein filament ( Figure 1B , ''ATP (Mg 2+ )''). BRC4 also increased RAD51-ssDNA complex formation when either dT 60 or dT 70 were used (data not shown). When an oligonucleotide with a random 26 nucleotide sequence was used, nucleoprotein complex formation was stimulated by BRC4 from 3% to 15%; the use of longer mixed sequence DNA resulted in complex formation with RAD51 that involved more than 75% of the DNA, precluding detection of stimulation by BRC4 (data not shown). The presence of the GST tag did not affect the results, as an untagged BRC4 peptide also stimulated binding ( Figure S2 ). When the concentrations of RAD51 were reduced (10-and 20-fold), both the profile and optimum for stimulation by BRC4 were proportionally shifted ( Figure 1C ), indicating that the stimulatory effect of BRC4 is the consequence of forming a defined complex with RAD51 and not a nonspecific effect (Davies et al., 2001; Galkin et al., 2005) ; at these lower concentrations, the binding of BRC4 to RAD51 is not stoichiometric, requiring excess amounts of BRC4 to drive binding to RAD51. To confirm that these effects were not unique to the BRC4 repeat, a domain corresponding to all eight of the BRC repeats, BRCA2 BRC1-8 , was examined (Shivji et al., 2006) . A similar profile of stimulation was observed with BRCA2 BRC1-8 ; due to limitations of the protein stock, higher BRCA2 BRC1-8 concentrations could not be examined ( Figure 1C ). This finding shows that the BRC4 repeat and BRCA2 BRC1-8 behave similarly. Interestingly, either when Ca 2+ replaced the Mg 2+ to prevent the hydrolysis of ATP (Bugreev and Mazin, 2004) or when the nonhydrolyzable analog, AMP-PNP, was used, BRC4 did not stimulate the binding of RAD51 to ssDNA but rather inhibited filament formation ( Figure 1B ). These results suggest that the stabilization of nucleoprotein filaments by BRC4 requires ATP hydrolysis by the nucleoprotein filament. Finally, BRC4 appeared to have little or no effect when ATP was replaced by ADP ( Figure 1B) but, because the ADP-complex is more stable than the ATP-bound form (Kim et al., 2002; unpublished data) , this increased stability precluded detection of a stabilizing effect. Therefore, to measure the effect of BRC4 on ADP-RAD51-ssDNA complexes, we examined the dissociation of these complexes due to elevated salt concentrations. Figure 1D shows that BRC4 increased the stability of the ADP-RAD51-ssDNA complexes against dissociation at high NaCl concentrations. Thus, BRC4 stabilizes RAD51-ssDNA filaments only when hydrolysis of ATP to ADP is permitted, or when ADP is present initially.
RESULTS

BRC4 and BRCA2
BRC4 Prevents ssDNA-Dependent ATP Hydrolysis by RAD51, thereby Maintaining the Active ATP-Bound Form of the Filament To understand the mechanism by which BRC4 stabilizes RAD51-ssDNA complexes, we explored the effect of BRC4 on the ssDNA-dependent ATPase activity of RAD51. BRC4 reduced ATP hydrolysis by RAD51 for all the ssDNA examined, both homopolymers and natural DNA (Figure 2A ). In the absence of BRC4, the rate of ATP hydrolysis was fastest for the shorter ssDNA due, likely, to the more dynamic nature of the filaments on shorter DNA. In all cases, BRC4 reduced the hydrolysis rate to the DNA-independent rate, while the control peptide had no effect (Figure 2A ). This inhibition of ATP hydrolysis was not due to dissociation of the nucleoprotein filaments since BRC4 stabilized the complexes under these conditions (Figure 1) . Finally, BRC4 also inhibited similarly the ATPase activity of RAD51 when RPA was present ( Figure S3) , showing that the effects of BRC4 are not altered by RPA.
Because BRC4 could prevent ATP hydrolysis at a number of different steps in the ATP hydrolysis cycle (e.g., by blocking ATP binding, ADP dissociation, or the catalytic step), we sought to determine which nucleotide was bound to the BRC4-inhibited filament. To determine whether BRC4 affected the proportion of ATP and ADP bound to the RAD51 nucleoprotein, we used a modified version of an assay described previously (Bugreev and Mazin, 2004) . Nucleoprotein filaments were formed in the presence of [a- 32 P] ATP, isolated from free nucleotides, and then the nucleotide (ATP/ADP) composition of the filament was measured ( Figures 2B-2D ). BRC4 reduced the fraction of ADP bound and concomitantly increased the amount of ATP bound to nucleoprotein filaments formed on either dT 40 ( Figure 2B , upper panel) or fX174 ssDNA ( Figure 2B , lower panel). The relative increase in amount of nucleotide-bound (for both ATP and ADP) complexes (4-fold for dT 40 and more than 10-fold for fX174 ssDNA) correlates with the stabilization of the ssDNA complexes shown in Figure 1 . More significantly, in the presence of BRC4, the resulting filaments contain nearly 100% ATP ( Figure 2D ). These results provide direct evidence that BRC4 permits accumulation of the active, ATP-bound form of RAD51-ssDNA filament. Moreover, since BRC4 both stimulates the assembly of RAD51 onto ssDNA only when ATP hydrolysis is occurring ( Figure 1B ) and stabilizes the ADP-RAD51-ssDNA complex, these findings strongly suggest that BRC4 acts by preventing dissociation of ADP-RAD51 from ssDNA, permitting exchange of ATP for ADP within the filament, and finally blocking ATP hydrolysis. The consequence of these events is formation and preservation of the active ATP-RAD51-ssDNA nucleoprotein filament.
BRC4 and BRCA2 BRC1-8 Prevent the Formation of RAD51 Nucleoprotein Filaments on dsDNA
Given that RAD51 can bind both ssDNA and dsDNA (Baumann et al., 1996; Mazin et al., 2000) , but only the ssDNA nucleoprotein filament is functional (Sung and Robberson, 1995) , we next investigated the effect of BRC4 on the binding of RAD51 to dsDNA. RAD51 was incubated with increasing concentrations of BRC4 prior to addition of 32 P-labeled fX174 linear dsDNA ( Figure 3 ). As expected, BRC4 alone did not bind dsDNA ( Figure 3A , lane 1). However, in the presence of ATP, increasing concentrations of BRC4 inhibited binding of RAD51 to dsDNA, which is opposite to the behavior seen with ssDNA. The control peptides, D1524-30 and T1526A, did not prevent RAD51-dsDNA filament formation ( Figure 3A , lanes 9 and 10, and Figure 3B ). As with ssDNA binding, the GST tag did not affect the results since an untagged BRC4 peptide had the same effect ( Figure S4A ). The same outcome was obtained when fX174 dsDNA was substituted with a shorter duplex DNA, dT 40 $dA 40 ( Figure 3C ), and when BRCA2 BRC1-8 was employed instead of BRC4 ( Figure 3D ). When Ca 2+ was substituted for Mg 2+ , BRC4 still inhibited binding of RAD51 to dsDNA ( Figure S4B ). But when AMP-PNP was used instead of ATP, BRC4 did not inhibit RAD51 nucleoprotein filament formation ( Figure 3B ). The observation that BRC4 does not block RAD51-dsDNA binding in the presence of AMP-PNP but does so in the presence of ATP and Ca 2+ suggests that there is a difference in the structural conformation adopted by the BRC4-RAD51 filament that is dependent on the type of nucleotide cofactor and DNA. Previously, the amino-terminal domain of RAD51 in dsDNA filaments was found to become dynamic when ATP was used instead of AMP-PNP (Galkin et al., 2005) , and this structural flexibility suggests that BRC4 acts to destabilize the RAD51-dsDNA filament through a conformation state that is accessible only when the physiological cofactor ATP is present.
The BRC Repeats Prevent Nucleation of RAD51 onto dsDNA but Do Not Disrupt a RAD51-dsDNA Filament To understand the basis for the inhibition of RAD51-dsDNA complex formation by BRC4, we examined RAD51-dsDNA nucleoprotein filaments at the single-molecule level. A fluorescently labeled RAD51 protein (Hilario et al., 2008) was used to visualize RAD51 filament formation on dsDNA following a strategy reported previously for RecA protein (Galletto et al., 2006) . Briefly, a flow cell was used to generate three separate laminar flow channels ( Figure 4A ). In the capture channel (step 1), a biotinylated bacteriophage l DNA molecule, stained with the fluorescent intercalating dye, YOYO-1, and attached to a streptavidin-coated bead, was optically trapped. The bead-YOYO-1-DNA complex was then moved into the observation channel under conditions that dissociate the dye from DNA (step 2). This dye-free DNA was subsequently moved to the protein channel containing the fluorescently modified RAD51, alone, with BRC4, or with D1524-30 (step 3). After incubation for the specified times in the presence of ATP and Ca 2+ , the trapped DNA was moved into the observation channel (step 4) where the bound fluorescent-RAD51 was visualized. An example of a RAD51 filament formed by successively ''dipping'' a single dsDNA molecule in the protein channel for 20 or 30 s is shown in Figure 4B , left panel: within 20 s, RAD51 was seen along much of the dsDNA, and nucleoprotein filament formation was nearly complete in 60 s. In marked contrast, a 4:1 Figure 4D ). At the same concentration, the control D1524-30 peptide had no effect ( Figure 4B , right panel). These single-molecule results agree fully with our ensemble experiments ( Figure S4B ).
The RAD51 nucleation frequency was seen to depend on BRC4 concentration ( Figure 4D ): when reduced to 1:1 (BRC4:RAD51), nucleation was still low (1.7 ± 0.3 min À1 ), but upon further reduction to 0.5:1, the rate increased to 22 ± 3.8 min À1 (Figures 4C and 4D) . At the two concentrations tested, 0.5:1 and 2:1 (BRCA2 BRC1-8 :RAD51), the effect of BRCA2 BRC1-8 on the RAD51 nucleation rate was found to be comparable to that of BRC4 ( Figures 4C and 4D ), substantiating the results obtained with a single BRC repeat. In the absence of BRC4 or BRCA2 BRC1-8 , nucleation was too rapid to measure reliably. The effect of increasing peptide concentration on nucleus formation is summarized in Figure 4E ; maximal inhibition of nucleation occurred at an approximately equimolar ratio of BRC4 or BRCA2 BRC1-8 to RAD51. We next examined whether BRC4 can disrupt preformed RAD51-dsDNA filaments. RAD51 nucleoprotein filaments were formed in the protein channel as was done for the assembly experiments, except Mg 2+ was used instead of Ca 2+ to permit ATP hydrolysis and subsequent dissociation. Once the filament was fully extended ($4 min in these conditions), the DNA was moved to the second channel containing both Mg 2+ and ATP to commence disassembly. Within experimental error, when BRC4 was present in the second channel, the rate of disassembly of the preformed fluorescent RAD51-dsDNA filaments was unchanged ( Figure 5A ). The DNA length is proportional to the amount of RAD51 bound (Hilario et al., 2008) ; hence, measurement of the DNA length as a function of time permits quantification of the first order rate constant for dissociation. In the presence of BRC4, RAD51 disassembles at a rate of (C) The effect of BRC4 or BRCA2 BRC1-8 on RAD51-dsDNA complex formation using dA 40 $dT 40 dsDNA. RAD51 (0.15 mM) was incubated with GST-BRC4 or BRCA2 BRC1-8 , at the concentrations indicated prior to incubation with 32 P-labeled dA 40 $dT 40 dsDNA (2.4 mM, nt) and further incubation for 1 hr in the presence of ATP, Mg
2+
, and Ca
. Protein-DNA complexes were resolved in 6% PAGE and analyzed by autoradiography. (D) Data obtained as in (C), quantified and plotted in the presence of: GST-BRC4 (black circle); BRCA2 BRC1-8 (purple triangle). Error bars represent the SD from at least three independent experiments and, in some cases, are smaller than the symbol. 0.14 (±0.05) mm min À1 ; in its absence, the rate is 0.17 (±0.09) mm min À1 ( Figure 5B ). These data, both the visual presence of fluorescent RAD51 and the nucleoprotein length, demonstrate that BRC4 does not accelerate disassembly of the RAD51-dsDNA filament.
BRC4 Can Stimulate RAD51-Mediated DNA Strand Exchange Together, the ensemble-and single-molecule experiments indicate that BRC4 stabilizes the ATP-RAD51-ssDNA filament but blocks filament formation on dsDNA at the nucleation level. Therefore, we reasoned that BRC4 should also stimulate RAD51-mediated DNA strand exchange by both promoting filament assembly on ssDNA and preventing inhibitory filament formation on the target dsDNA. To test this prediction, we examined DNA strand exchange activity in the presence of RPA ( Figure 6A ). Initially, optimal conditions employing a stoichiometric amount of RAD51 relative to ssDNA were used (Benson et al., 1994; Bugreev and Mazin, 2004; Sung and Robberson, 1995) . As expected, at these conditions ( Figures 6B, left panel and 6C) RAD51 promoted the formation of DNA strand exchange products, joint molecules, and nicked circular dsDNA. At these conditions, BRC4 showed a negligible stimulation of product formation compared to the control D1524-30 peptide, although BRC4 did inhibit product formation at high concentrations ( Figures S5A and S5B ) due to inhibition of RAD51 binding to the fX174 ssDNA at these higher BRC4 concentrations (data not shown; see Figure 1C ). However, it is well known that when the RAD51 concentration exceeds the stoichiometric optimum with regard to ssDNA, RAD51 self-inhibits DNA strand exchange in vitro by binding to the dsDNA target (Benson et al., 1994; Sung and Robberson, 1995) . Indeed, increasing the RAD51 concentration to 6 mM reduced product formation ( Figure S5C , first lane), and increasing further to 7.5 mM nearly completely blocked all product formation ( Figure 6B , right panel, lanes labeled ''0'' peptide). As predicted from our binding studies, however, BRC4 restored product formation in a concentration-dependent manner ( Figures 6B, 6C , S5C, and S5D). The effect was most dramatic at the highest RAD51 protein concentrations ( Figures 6B and 6C) , and in fact, BRC4 increased the yield of the fully strand-exchanged DNA product (the nicked circular dsDNA) to levels that were higher than even the optimal reaction (at 3.75 mM RAD51 [ Figures 6B and 6C] ; the control peptides, T1526A and D1524-30, had no effect in any reaction [Figures 6B, 6C, S5A, and S5B] ). Thus, these results reveal a previously unrecognized ability of BRC4 to stimulate RAD51-mediated DNA strand exchange.
DISCUSSION
Taken together, our results show that both BRC4 alone and BRCA2 BRC1-8 can modulate RAD51 filament formation in two mutually reinforcing ways: stimulating the assembly on ssDNA and preventing nucleation onto dsDNA. This duality with regard to control of RAD51 nucleoprotein filament formation is, in turn, responsible for the regulation of RAD51-promoted DNA strand exchange. Our results demonstrate that the interaction of the BRC repeats with RAD51 is sufficient to enhance RAD51 filament assembly on ssDNA ( Figure 7A , step 1). This enhancement results from both an inhibition of ATP hydrolysis ( Figure 7A , step 2) and a stabilization of the ADP-bound form of the nucleoprotein filament ( Figure 7A, step 3) . The combined consequence is to allow exchange for ATP within the filament rather than the dissociation of ADP-RAD51 from the ssDNA. The net effect is maintenance of a protein filament assembled on ssDNA in its A break in dsDNA is resected to produce ssDNA. RPA binds to the ssDNA, hindering RAD51 filament assembly. BRCA2 binds to the dsDNA-ssDNA junction, and loads RAD51 onto the ssDNA but blocks assembly onto the dsDNA. RAD51 filament growth extends the BRCA2-stablized nucleus to form an ATP-bound nucleoprotein filament capable of homologous DNA pairing. Blue spheres represent a RAD51 monomer, T represents ATP, and D represents ADP; RPA is in orange, BRCA2 is brown, and the BRC repeats are represented in purple.
ATP-bound form, which is the form that is required for DNA pairing function. In addition, the BRC repeats prevent a competing inhibitory reaction: namely, the nonfunctional assembly of RAD51 on dsDNA ( Figure 7B, step 4) . The BRC repeats achieve this function by blocking the rate-limiting nucleation of filaments on dsDNA. The similar results obtained with a domain comprised of the eight BRC repeats, BRCA2 BRC1-8 , previously shown to stimulate RAD51-mediated DNA strand exchange (Shivji et al., 2006) , support the conclusions obtained with the single BRC4 repeat, and they further suggest that the entire BRCA2 BRC1-8 domain behaves as a regulator of DNA binding, much like BRC4. Our conclusions are also consistent with recent independent observations on the regulation of RAD51 DNA binding by BRCA2 BRC1-8 protein (M.K.K.S., E. Rajnedra, J. Savill, and A.R.V., unpublished data). Crystallographic analysis defined an interaction interface between BRC4 and RAD51 that involves the ATPase core of RAD51 and that mimics the intermonomer interactions within the filament (Pellegrini et al., 2002) . It was found that the nucleotide-binding site of RAD51 adopts a more closed conformation when bound to BRC4, and the authors suggested that this conformation might, in turn, alter ATP occupancy. This interpretation could provide a structural explanation for the inhibition of the ATPase activity of RAD51 by BRC4 and the resultant stabilization of RAD51-ssDNA filaments if the ATP-binding pocket closed with ATP bound and BRC4 prevented the conformational changes needed for ATP hydrolysis.
Paradoxically, BRC repeats were also shown both to disrupt RAD51 nucleoprotein filament formation on dsDNA and to bind to these nucleoprotein filaments. This seemingly contradictory outcome is likely a consequence of the two different binding modes reported for the BRC repeats: a mode that binds RAD51 in a monomeric state and another that binds the nucleoprotein filament (Davies et al., 2001; Galkin et al., 2005; Pellegrini et al., 2002) ; a third interaction mode, described for the C-terminal region of BRCA2, reportedly involves oligomeric RAD51 binding (Davies and Pellegrini, 2007; Esashi et al., 2007) . Some prior studies are seemingly contradictory to some of the observations reported here, but our studies readily rationalize those findings. We showed that BRC4 will not inhibit RAD51 filament formation on dsDNA, unless the RAD51 is allowed to dissociate via ATP hydrolysis; once dissociated, however, our studies also show that reassembly of the dissociated RAD51 protein will be blocked by BRC4, leading to an apparent disruption of the ATP-nucleoprotein filaments. For this reason, nucleoprotein filaments formed on dsDNA in the presence of the nonhydrolyzable analog, AMP-PNP, are much less affected by BRC repeats, whereas those assembled in the presence of ATP are apparently disrupted; however, these latter complexes are not, in fact, disrupted by the BRC repeat but, instead, they dissociate normally and their reassembly is blocked on a steady-state kinetic basis. In addition, BRC4 was found to inhibit the binding of RAD51 to longer ssDNA (e.g., poly(dT)) (Davies and Pellegrini, 2007) . However, here we discovered that there are two distinct regimes of BRC4 behavior with regard to RAD51 binding to ssDNA: stimulation at low concentrations of BRC4 and inhibition at high concentrations. Because RAD51 forms unstable complexes with short oligonucleotides, such as dT 40 or dT 60 , we can detect both the stimulatory regime and the inhibitory regime (Figure 1) . However, for longer ssDNA, the binding of RAD51 is stable (close to 100% binding); thus, the stimulatory behavior cannot be detected, and only the inhibitory behavior is seen. This dichotomous behavior resolves the apparent discrepancy with studies using ssDNA that forms stable complexes with RAD51.
It was recently reported that a peptide derived from the BRC repeat of BRCA2 can inhibit the binding of RAD51 to the fluorescently modified ssDNA, poly(etheno-dA) (Nomme et al., 2008) ; in agreement, we observed a similar behavior with M13 etheno-ssDNA (unpublished data). We conclude that the fluorescent modification of these ssDNA substrates precludes the stimulation of binding seen for BRC4 with the unmodified ssDNA. Our results show that these distinct modes of action may have disparate consequences that depend on the type of DNA, single-or double-stranded, involved.
When considered in conjunction with previous work that showed that BRC repeats are necessary to target RAD51 to ssDNA (San Filippo et al., 2006) , our findings suggest that the dominant-negative phenotype resulting from expression of the single BRC4 in vivo (Chen et al., 1999) arises either from the inability of an isolated repeat, without the DNA-binding domains of BRCA2, to efficiently deliver RAD51 to the site of a processed dsDNA break or from an inhibitory effect of excessive BRC4 expression. Consistent with the former interpretation, expression of a fusion of BRC4 and the ssDNA-binding domain of a heterologous protein, RPA, restores recombinational DNA repair in mammalian cells to nearly wild-type levels (Saeki et al., 2006) . In agreement with the latter possibility, high concentrations of BRC4 block DNA strand exchange in vitro ( Figures  S5A and S5B) .
The BRCA2 homolog from C. elegans, CeBRC2, which possesses a single BRC repeat, was reported to reduce the rate of ATP hydrolysis by CeRAD51 in vitro and to promote persistent CeRAD51 nucleoprotein focus formation in vivo (Petalcorin et al., 2007) . In agreement, here we showed that a single BRC repeat from the human BRCA2 is sufficient to stabilize the human RAD51-ssDNA nucleoprotein complex by decreasing ATP hydrolysis and by both stabilizing and increasing the fraction of active ATP-bound nucleoprotein filaments on ssDNA ( Figures 2B and 2C) . Collectively, the published reports and our results support the conclusion that BRC repeats enhance the DNA pairing activity of RAD51 by slowing ATP hydrolysis. Interestingly, a similar mechanism was invoked to explain the Ca 2+ -dependent stabilization of the RAD51-ssDNA filament and the consequent stimulation of DNA strand exchange (Bugreev and Mazin, 2004) . The accumulation of the ATP-bound form of the filament by either Ca 2+ or BRC4 promotes formation of an active nucleoprotein filament on ssDNA that is necessary for DNA strand exchange. The interaction with the BRC repeats goes one step further: it limits the nonproductive formation of filaments on dsDNA. Thus, the BRC repeats show two different modes of interaction: one that stabilizes RAD51-ssDNA filaments by modulating ATPase activity and another that prevents nucleation of filaments on dsDNA ( Figures 7A and 7B) . Further research will be required to understand how the BRC repeats and the C-terminal region orchestrate RAD51 nucleoprotein formation in the context of entire BRCA2 protein and throughout the cell cycle. However, our observations have revealed an unexpected dichotomy of the seemingly simple BRC repeats in controlling RAD51 nucleoprotein filament assembly that might be crucial for understanding the role of BRCA2 in the DNA-damage response and repair. In Figure 7C , we illustrate the likely function of the intact BRCA2 protein.
Duplex DNA that suffers a DSB is resected to produce ssDNA. The ssDNA is initially bound by RPA, precluding the binding of RAD51 and necessitating a catalyst to facilitate assembly of RAD51 on the ssDNA (Sugiyama and Kowalczykowski, 2002) . BRCA2 is proposed to bind to the ssDNA-dsDNA junction by virtue of its DNA-binding domain, which comprises both ssDNAand dsDNA-binding domains (Yang et al., 2002 . The BRC repeats recruit RAD51 to this junction and load RAD51 onto the ssDNA, but they block its nonproductive assembly onto dsDNA. The major role of BRCA2 is seen as nucleating the nucleoprotein filament near the junction by preventing turnover of the nascent nucleus of the ATP-bound RAD51 filament. Once a nascent filament forms, growth and RPA displacement ensue, likely aided by other mediators such as RAD52 (Benson et al., 1998; New et al., 1998; Shinohara and Ogawa, 1998; Sung, 1997; Sung et al., 2003) .
EXPERIMENTAL PROCEDURES Protein Expression and Purification
See Supplemental Data.
Electrophoretic Mobility Shift Assay
The procedure was essentially as described (Galkin et al., 2005) . RAD51 was preincubated with GST-tagged BRC4, BRCA2 BRC1-8 , D1524-30, or T1526A at the indicated concentrations for 15 min, followed by addition of ssDNA (dT 40, labeled with 32 P at the 5 0 end) or dsDNA (XhoI-linearized fX174 dsDNA, 32 P-labeled at the 5 0 end or 32 P-5 0 end labeled duplex dT 40 $dA 40 prepared by annealing), at the concentrations indicated, in buffer containing 20 mM Tris-HCl (pH 7.5), 10 mM Mg(OAc) 2 , 2 mM CaCl 2 , 2 mM ATP, 100 mg/ml BSA. The mixture was incubated for 15 min or 60 min at 37 C, as indicated.
The reaction products were resolved by 6% PAGE at 4 C in 13 TAE, (40 mM Tris-acetate, pH 7.5, 0.5 mM EDTA) or using 0.5% agarose gels at 40 V o/n (in the case of fX174 dsDNA) in 13 TAE. Where indicated, ATP was replaced with ADP or AMP-PNP (2 mM), and Mg 2+ and Ca 2+ were replaced by either Mg 2+ (10 mM) or Ca 2+ (2 mM). The agarose gels were dried and analyzed on a Molecular Dynamics Storm 840 PhosphorImager using ImageQuant software. The percentage of protein-DNA complexes was quantified as the free radiolabeled DNA remaining in a given lane relative to the protein-free lane, which defined the value of 0% complex (100% free DNA).
ATP Hydrolysis Assay RAD51 (3 mM) was preincubated with the GST-tagged BRC4, or D1524-30, at 37 C for 15 min, followed by addition of ssDNA (9 mM nucleotides, nt) in 10 ml of buffer containing 20 mM TrisHCl (pH 7.5), 4 mM MgCl 2 , 1 mM DTT, 0.5 mM ATP, and 20 mCi/ml [g 32 P]ATP, and further incubated at 37 C for 1 hr. In Figure S3 , RPA (1 mM) or RPA storage buffer was preincubated with dT 40 (9 mM nt) for 5 min at 37 C, followed by the addition of RAD51 (3 mM) and the concentrations specified of GST-tagged BRC4 in the same buffer as above, and incubated at 37 C for 1hr. Aliquots (1 ml) were spotted onto a polyethyleneimine (PEI) thin layer chromatography (TLC) plate (EMD Chemicals). The spots were air-dried and the plates were developed in 1 M formic acid and 0.5 M LiCl. The amount of ATP hydrolyzed was determined from dried plates using a Molecular Dynamics Storm 840 PhosphorImager. when BRC4 was absent. The ATP and ADP bound to free RAD51 was determined in parallel by doing the same experiment in the absence of DNA and was subtracted from each lane of the experiment done in the presence of DNA.
Single-Molecule Visualization
The experimental protocol was similar to that reported previously (Bianco et al., 2001; Galletto et al., 2006) . A three-channel flow cell (4.5 mm wide and 70 mm deep) generated three 1.5 mm laminar flow paths. Bacteriophage l DNA, biotinylated at one end, was attached to a 1 mM streptavidin-coated polystyrene bead (Bangs Laboratories). The bead-DNA complex in buffer T (50 mM TrisOAc, pH 8.3, 15% sucrose, and 30 mM DTT), containing 10-20 nM YOYO-1, was trapped at a linear flow rate of 180 mm s À1 at 25 C.
The trapped bead-l DNA complex was then moved to the observation channel, which contained buffer T and 5 mM Ca(OAc) 2 , where the YOYO-1 dissociated from the DNA in less than 1 min. The YOYO-1 allowed measurement of DNA length and verification that a single DNA molecule was captured. The bead-l DNA complex was then moved to the protein channel containing the fluorescent RAD51 (using carboxyfluorescein succinimidyl ester coupling to the N-terminal amino group at pH 7.0 [Galletto et al., 2006] ) in buffer T containing 2 mM Ca(OAc) 2 with 1 mM ATP and GST-tagged BRC4, D1524-30, or BRCA2 BRC1-8 at the concentrations specified. After each incubation time, the protein-DNA-bead complex was moved back to the second channel for direct observation. The dissociation experiment was conducted by forming the RAD51 nucleoprotein filament in the protein channel in buffer T containing 1 mM ATP, 2 mM Mg(OAc) 2 , and 250 nM RAD51. After 4 min of incubation, the filament was moved to the observation channel in buffer T containing 2 mM ATP and 10 mM Mg(OAc) 2 , with or without 1 mM GST-BRC4. The length of the l DNA was calculated from 11 molecules, corrected for the radius of the bead and for extension due to the YOYO-1 dye. All the experiments were conducted using illumination from a mercury lamp, and fluorescence was observed using a FITC filter (Chroma Technology Corp., number 41001). Data were collected on S-VHS tapes, digitized, and analyzed with Image J software and associated plug-ins.
DNA Strand Exchange Assay
Reactions (20 ml) were as described (Bugreev and Mazin, 2004) . RAD51 and GST-tagged BRC4 or the control peptides D1524-30 and T1526A, at the concentrations indicated, were incubated with fX174 ssDNA (15 mM, nt) for 5 min at 37 C in buffer containing 25 mM TrisOAc, pH 7.5, 250 mM NaCl, 2 mM ATP, 1 mM DTT, 1 mM MgCl 2 , 2 mM CaCl 2 . RPA (1 mM) was then added, and incubation continued for 5 min at 37 C. The reaction was started by the addition of XhoI-linearized 32 P-labeled fX174 duplex DNA (15 mM, nt). After 2 hr at 37 C, the samples were treated with Proteinase K (Roche) for 15 min at 37 C. Products were resolved by electrophoresis on a 1% agarose gel
(1 X TAE) at 40 V overnight. The gels were dried and analyzed on a Molecular Dynamics Storm 840 PhosphorImager using ImageQuant software. The amount of DNA strand exchange product at each BRC4 concentration was calculated as a percentage of the joint molecules (JM) or nicked circular DNA (NC) products relative to the total amount of DNA in the same lane.
Analysis
In all graphs, error bars represent the standard deviation derived from at least three independent experiments and, in some cases, error bars are smaller than the symbol; all analyses used GraphPad Prism (version 5.01).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and five figures and can be found with this article online at http://www.cell.com/ supplemental/S0092-8674(09)00161-5.
